April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
OncoDaily Leukemia 2024

OncoDaily Leukemia 2024

OncoDaily in collaboration with MDS Foundation, Yerevan State Medical University, Yeolyan Hematology and Oncology Center, Immune Oncology Research Institute and the Armenian Association of Hematology and Oncology is happy to invite you to the OncoDaily Leukemia Conference which will take place on April 25-27 in Yeolyan Hematology and Oncology Center, Yerevan, Armenia.

Join us at the “OncoDaily Leukemia Conference in cooperation with MDS Foundation,” where experts in hematology come to exchange insights, advancements, and strategies in the field of leukemia and related disorders.

To register for the conference please click here

Save the date: 25-27 April | Entrance: Free

Venue: Yeolyan Hematology and Oncology Center | 7 Nersisyan st., Yerevan, Armenia 

Below are several distinguished speakers who will be presenting at the OncoDaily Leukemia Conference and the Agenda of the conference.

         

Day 1 – April 25

09:00-09:30 Opening

09:30 – 10:10

How I manage Acute Lymphoblastic Leukemia in Children

Scott Howard, MD (USA) – online

Deputy Director of the Yeolyan Hematology and Oncology Center
Chief Development Officer at the SJD Barcelona Cancer Center
CEO of Resonance

10:10 – 10:50

How I Manage Acute Lymphoblastic Leukemia in Adults

Marina Konopleva, MD, PhD (USA)

Professor of Oncology and Molecular Pharmacology
Director of the Leukemia Program
Co-Director of the Blood Cancer Institute at Montefiore Einstein
Professor of Leukemia Department at MD Anderson Cancer Center

10:50 – 11:30

Progress of leukemia research over the past decades: my personal experience

Giuseppe Saglio, MD, PhD (Italy)

Professor of Internal Medicine and Haematology and Director of the Department of Clinical and Biological Sciences at the University of Turin

11:30-12:00  Coffee Break

12:00 – 12:40

How to diagnose and treat CML in 2024

Giuseppe Saglio, MD, PhD (Italy)

Professor of Internal Medicine and Haematology and Director of the Department of Clinical and Biological Sciences at the University of Turin

12:40 – 13:20

Bridging the Gap: Translational Research in Hematology 

Sylvain Garciaz MD, PhD (France) – online

Professor at Maître de Conférence des Universités- Praticien Hospitalier Département d’hématologie Institut Paoli Calmettes, Marseille, France

13:20 – 14:00

Conducting Phase 1 trials: challenges and opportunities

Mikhail Groubman, PhD (Russia)

CEO of Atlant Clinical; Chair of the Board of the Immune Oncology Research Institute

14:00-15:00 Lunch

15.00 – 15:40

Cellular therapies in leukemias

Nerses Ghahramanyan, MD (Armenia)

Chief of the Adults Hematology Outpatient Department at the Yeolyan Hematology and Oncology Center

15:40–16:20

BPDCN: Diagnosis, Treatment, and International Registry

Astghik Voskanyan, MD (Armenia)

Deputy Director and Head of Adult Hematology Clinic at the Yeolyan Hematology and Oncology Center; Clinical Research Physician and Lead of Hematology at the Immune Oncology Research Institute; PI of the BPDCN International Registry

16:20 – 17:00

T cell prolymphocytic leukemia: a case report and literature review

Lusine Harutyunyan, MD (Armenia) 

Hematologist at the Yeolyan Hematology and Oncology Center; Research Fellow at the Immune Oncology Research Institute

17:00-17:40

Vexas Syndrome and MDS

Arsene Mekinan, MD, PhD (France) – online

Professor of Medicine at the University of Paris; Visiting Professor at Yerevan State Medical University; President of Santé Arménie

17:40-18:00

Closing

 

Day 2 – April 26

09:30 – 10:10

Molecular Advances in the Understanding of Myelodysplastic Syndromes (MDS)

Peter Greenberg, MD (USA) – online

Professor of Medicine and Director of the Stanford MDS Center, Stanford University

10:10 – 10:50

Cutting-Edge Therapeutic Strategies for Acute Myeloid Leukemia (AML)

Marina Konopleva, MD, PhD (USA)

Professor of Oncology and Molecular Pharmacology, Director of the Leukemia Program, Co-Director of the Blood Cancer Institute at Montefiore Einstein, Professor of Leukemia Department at MD Anderson Cancer Center

10:50-11:30

Case Report Session

Nare Martirosyan, MD (Armenia)

Hematologist at the Yeolyan Hematology and Oncology Center

Meri Petrosyan, MD (Armenia)

Pediatric oncologist and hematologist, a fellow of clinical immunology at Yeolyan Hematology and Oncology Center

11:30-12:20
 Coffee Break

12:20 – 13:20

Case Report Session

Araksia Vanoyan, MD (Armenia)

Hematologist at the Yeolyan Hematology and Oncology Center

Grigor Vardanyan, MD (Armenia)

Hematologist at the Yeolyan Hematology and Oncology Center

Hasmik Maghakyan, MD (Armenia)

Medical Resident at the Yeolyan Hematology and Oncology Center

14:00-15:00
Lunch     

15:00 – 15:40

Diagnosis and Management of Patients with MDS in Armenia

Anna Sevoyan, MD (Armenia)

Hematologist at the Yeolyan Hematology and Oncology Center

15:40 – 16:20

How I Treat Low Risk MDS

Gabriele Todisco (Italy) – online

Assistant Professor at Humanitas University

16:20 – 17:00

How I Treat High Risk MDS

Rami Komrokji, MD (USA) – online

Vice chair of Malignant Hematology Department and Head of the Leukemia and MDS Section at Moffitt Cancer Center; Professor of Medicine & Oncologic Sciences at the College of Medicine at the University of South Florida

17:00 – 17:40

Updates to Diagnosis/Classification of MDS and AML

Robert Hasserjian, MD (USA) – online

Director, Hematopathology Fellowship Program, Pathology Service at Massachusetts General Hospital; Professor of Pathology at the Harvard Medical School

17:40-18:00

Closing

 

Day 3 – April 27

10:00 – 10:40

Development of Oral Azacitidine with Cedazuridine for Myelodysplastic Syndrome (MDS) and Myeloproliferative Neoplasms (MPN) including CMML (Chronic Myelomonocytic Leukemia) by Targeting Pharmacokinetic AUC Equivalence vs Subcutaneous Azacitidine

Aram Oganesian, PhD, DABT (USA)

Vice-President, Clinical Pharmacology Taiho Oncology

MDS Patient Forum

10:40 – 12:00

Anna Sevoyan, MD (Armenia)

Hematologist at the Yeolyan Hematology and Oncology Center